Inmed Pharmaceuticals revenue was $4.83M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.1M, down 12.1% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, INM annual revenue was $4.6M, with 11.2% growth year-over-year.
INM past revenue growth
How has INM's revenue growth performed historically?
On Invalid Date, Inmed Pharmaceuticals (NASDAQ: INM) reported Q4 2024 revenue of $1.11 million up 10.36% year over year. In the same quarter last year, Inmed Pharmaceuticals's revenue was $1.24 million.
What was Inmed Pharmaceuticals's revenue in 2024?
Inmed Pharmaceuticals's annual revenue for the twelve months ending Jun 30, 2024 was $4.60 million, a 11.18% increase year over year.
How much does Inmed Pharmaceuticals make in a day?
Based on Inmed Pharmaceuticals annual revenue for the past five years, INM makes an average of $5,382.32 per day.
What was Inmed Pharmaceuticals's annual revenue growth in the past year?
As of Q1 2025, Inmed Pharmaceuticals's revenue has grown -11.94% year over year. This is 1,138.27 percentage points lower than the US Biotechnology industry revenue growth rate of 1,126.33%. Inmed Pharmaceuticals's revenue in the past year totaled $4.83 million.
How much does Inmed Pharmaceuticals make in a year?
Inmed Pharmaceuticals's revenue by year for the past five years is:
Inmed Pharmaceuticals's revenue for the twelve months ending Jun 30, 2024 was $4.60 million, a 11.18% increase year over year.
Inmed Pharmaceuticals's annual revenue for Jun 30, 2023 was $4.14 million, a 279.61% increase from 2022.
Inmed Pharmaceuticals's annual revenue for 2022 was $1.09 million, a Infinity% increase from 2021.
Inmed Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Inmed Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.